Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reaffirmed at HC Wainwright
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a report released on Monday,Benzinga reports. They presently have a $69.00 target price on the stock. HC Wainwright’s target price points to a potential upside of 22.95% from the stock’s previous close. Several other research analysts […]
More Stories
Arctic Star Exploration (CVE:ADD) Shares Down 33.3% – Should You Sell?
Shares of Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) traded down 33.3% during trading on Monday . The...
Lithium ION Energy (CVE:ION) Stock Price Up 25% – What’s Next?
Lithium ION Energy Ltd. (CVE:ION – Get Free Report)’s stock price rose 25% during mid-day trading on Monday . The...
Insider Buying: OneWater Marine Inc. (NASDAQ:ONEW) CEO Buys 13,000 Shares of Stock
OneWater Marine Inc. (NASDAQ:ONEW – Get Free Report) CEO Philip Austin Jr. Singleton acquired 13,000 shares of OneWater Marine stock...
Bruce K. Posey Sells 855 Shares of Qualys, Inc. (NASDAQ:QLYS) Stock
Qualys, Inc. (NASDAQ:QLYS – Get Free Report) insider Bruce K. Posey sold 855 shares of the company’s stock in a...
Insider Selling: Jack in the Box Inc. (NASDAQ:JACK) SVP Sells 1,688 Shares of Stock
Jack in the Box Inc. (NASDAQ:JACK – Get Free Report) SVP Sarah L. Super sold 1,688 shares of the stock...
Tradr 2X Short TSLA Daily ETF (NASDAQ:TSLQ) Plans $1.32 Dividend
Tradr 2X Short TSLA Daily ETF (NASDAQ:TSLQ – Get Free Report) announced a dividend on Monday, December 23rd,NASDAQ Dividends reports....